REPROLIFE
Biotechnology - Tokyo, , Japan
REPROLIFE Details
REPROLIFE provides Cryotec® products based on the latest technology of vitrification of human oocytes and embryos developed in 2012 by Dr. Masashige Kuwayama. Eighteen significant improvements have been made from his past Cryotop Method of 2000. Foremost, by strict adherence to the protocol of The Cryotec Method, the embryologist is assured of achieving 100 % survival of normal oocytes and embryos. REPROLIFE was established as the expertise in vitrification of human oocytes and embryos and continuously aims to be the world's leading organization in bringing babies to many patients with a lot of happiness and hope.Website: http://cryotech-japan.jp/ Contact: contact@cryotech-japan.jp
REPROLIFE Technologies
Email Providers
Gmail
Other
Google Apps